Detalhe da pesquisa
1.
Precision diagnostics in lymphomas - Recent developments and future directions.
Semin Cancer Biol
; 84: 170-183, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699973
2.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Blood
; 137(10): 1365-1376, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992344
3.
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology.
Genes Chromosomes Cancer
; 61(1): 27-36, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647650
4.
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Haematologica
; 106(1): 87-97, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974198
5.
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Acta Oncol
; 60(4): 531-538, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579170
6.
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients.
Br J Haematol
; 191(3): 426-432, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779190
7.
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
Am J Hematol
; 95(1): 57-67, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659781
8.
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
Semin Cancer Biol
; 51: 1-11, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427646
9.
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Int J Cancer
; 144(11): 2695-2706, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447004
10.
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
Haematologica
; 104(2): 360-369, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262567
11.
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
Blood
; 127(8): 1007-16, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26675346
12.
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.
Blood
; 128(23): 2666-2670, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27670424
13.
NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
Semin Cancer Biol
; 39: 40-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27491692
14.
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
Blood
; 125(5): 856-9, 2015 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25634617
15.
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
Haematologica
; 101(8): 959-67, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198719
16.
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
Haematologica
; 100(3): 370-6, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480502
17.
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.
Haematologica
; 99(8): 1285-91, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082786
18.
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia.
Leukemia
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575671
19.
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
Br J Haematol
; 162(2): 221-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23668599
20.
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.
Haematologica
; 103(4): e158-e161, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269523